Universe Pharmaceuticals INC
UPC
$4.20
$0.4010.53%
NASDAQ
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,731.34% | -1,731.34% | 47.96% | 47.96% | -141.31% |
| Total Depreciation and Amortization | -3.49% | -3.49% | 3.80% | 3.80% | -11.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,534.19% | 3,534.19% | -115.02% | -115.02% | 142.81% |
| Change in Net Operating Assets | -113.21% | -113.21% | -6.31% | -6.31% | 3.02% |
| Cash from Operations | -150.63% | -150.63% | 50.49% | 50.49% | -21.57% |
| Capital Expenditure | -11,166.67% | -11,166.67% | -14.74% | -14.74% | 98.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11,166.67% | -11,166.67% | 98.87% | 98.87% | 98.91% |
| Total Debt Issued | 122.39% | 122.39% | -61.43% | -61.43% | 157.14% |
| Total Debt Repaid | 3.19% | 3.19% | -97.32% | -97.32% | 10.07% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 191.58% | 191.58% | -204.00% | -204.00% | 10,505.00% |
| Foreign Exchange rate Adjustments | -98.41% | -98.41% | 17.89% | 17.89% | 215.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.62% | -50.62% | 10.04% | 10.04% | 17.61% |